An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone online asked whether GLP-1 drugs (the class that includes Ozempic and Wegovy) interact with hormone replacement therapy (HRT) during perimenopause. The person is perimenopausal, has polycystic ovary syndrome (PCOS) and prediabetes, and has been on a GLP-1 medication for about two years. They say inflammation, PCOS symptoms, blood sugar (A1C), and even OCD symptoms improved, but weight loss has been modest — about 11 pounds — while they hoped for 30–40 pounds. GLP-1 medications are drugs that copy a natural gut hormone called glucagon‑like peptide 1. That hormone helps control appetite, slows how fast the stomach empties, and tells the pancreas to release insulin when glucose is high. People usually take these drugs for diabetes or for weight loss. They aren’t hormones like estrogen or progesterone; they work on appetite and blood sugar through a different pathway in the brain and gut. What this post shows is a real-world question more than a formal study. It’s one person’s experience and a request for others’ experiences. Their GLP-1 helped metabolic and mental-health symptoms but produced only modest weight loss over two years. That’s useful to know because clinical trials show variable weight loss: some people lose a lot, many lose a moderate amount, and some lose little. Also, people with PCOS, changing hormones in perimenopause, and different starting weights often respond differently. The post doesn’t provide systematic data, so it can’t prove whether HRT helps or hurts GLP-1’s weight-loss effects. Why this matters is simple: many people in midlife juggle changing hormones, insulin resistance, and weight. If HRT (estrogen and/or progesterone) changed how well GLP-1 drugs work, that would affect treatment choices. The person’s report suggests GLP-1s can still improve blood sugar and some PCOS symptoms even if weight loss is slower than hoped. That’s encouraging for people whose main goal is metabolic health or symptom relief, but it also highlights that weight loss isn’t guaranteed and may need additional strategies like diet tweaks, exercise, sleep, and medical follow-up. Caveats: this is an anecdote, not a clinical trial. We don’t know which specific GLP-1 drug or dose they used, whether they also changed diet or activity, or whether they’re on HRT now or asking about starting it. Side effects of GLP-1s can include nausea, digestive upset, and rare concerns like pancreatitis; HRT has its own risks and benefits that depend on age and health history. Anyone thinking about combining HRT and a GLP-1 drug should discuss it with their doctor so choices reflect personal risk factors and treatment goals. Bottom line: GLP-1 drugs can help blood sugar and some symptoms in perimenopause and PCOS, but weight loss varies a lot; this single report is interesting but not conclusive about HRT’s role.
Source: r/Mounjaro